Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lepu Biopharma Co., Ltd. has announced a proposed change of auditor, with PricewaterhouseCoopers resigning and the company planning to appoint Ernst & Young as its new auditor for 2024. This transition, recommended by the Audit Committee, is pending approval at the upcoming extraordinary general meeting and is based on Ernst & Young’s industry experience and market reputation.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.